Spinal Cord Stimulation for Painful Diabetic Neuropathy: Evidence, Patient Selection, and Real-World Outcomes
Details
- Date
- Sunday, January 24, 2027
- Time
- 8:00 AM – 9:30 AM
- Session type
- Concurrent Session
- Track
- Pain
- Schedule
- See this day
About
Painful diabetic peripheral neuropathy (PDPN) is among the most common and disabling complications of diabetes mellitus and remains a significant source of chronic neuropathic pain, impaired function, sleep disturbance, and reduced quality of life. Despite widespread use of anticonvulsants, antidepressants, and opioid-based therapies, many patients continue to experience refractory pain with limited long-term benefit. Recent advances in spinal cord stimulation (SCS) have transformed the treatment landscape for PDPN. Randomized clinical trials, including SENZA-PDN, have demonstrated substantial improvements in pain reduction, neurologic function, sleep quality, and patient-reported outcomes among appropriately selected patients. As evidence supporting neuromodulation continues to expand, clinicians increasingly face questions regarding patient selection, timing of referral, durability of benefit, and practical implementation within multidisciplinary diabetes care. This session will review the evolving evidence base supporting SCS for PDPN, including randomized controlled trials, long-term follow-up data, and emerging real-world outcomes. Faculty will discuss mechanisms underlying neuromodulation in diabetic neuropathy, identify appropriate patient selection criteria, and examine implementation strategies for integrating SCS into routine clinical practice. Long-term outcomes, durability, cost-effectiveness, and future directions in neuromodulation for PDPN will also be addressed. Through expert-led presentations and case-based discussion, attendees will gain a practical framework for evaluating spinal cord stimulation as a therapeutic option for patients with refractory painful diabetic neuropathy.
Presenters
-
.jpeg.jpg)
Dr. Murphy is a fellowship-trained, double-board-certified interventional pain specialist at Ortho Texas in the Dallas-Fort Worth, TX area. Dr. Murphy operates with a deep sense of compassion and dedication to cutting-edge technology, patient care, and research. Her disciplined, thoughtful, and reliable approach to medicine reflects her passion for improving lives. A graduate of Vanderbilt University, Dr. Murphy was honored as one of the Top Ten Outstanding Seniors. She received a full scholarship to Texas Tech Medical School and completed her residency at Vanderbilt and a fellowship at Northwestern Medicine in Chicago. She is double board-certified in anesthesiology and pain medicine.
Dr. Murphy’s bicultural background enhances her adaptability and global perspective, contributing to her success. Among her many accolades, she has been named Chair of Innovation and Growth for the United Musculoskeletal Partners National Leadership Board, executive board member/Treasurer at the American Society of Pain and Neuroscience (ASPN), and Chair of the Women in Neuromodulation (WIN) committee at the North America Neuromodulation Society (NANS). In addition, she has delivered over 100 talks worldwide, advancing spinal cord stimulation and pain management. -
Dr. Murphy is a fellowship-trained, double-board-certified interventional pain specialist at Ortho Texas in the Dallas-Fort Worth, TX area. Dr. Murphy operates with a deep sense of compassion and dedication to cutting-edge technology, patient care, and research. Her disciplined, thoughtful, and reliable approach to medicine reflects her passion for improving lives. A graduate of Vanderbilt University, Dr. Murphy was honored as one of the Top Ten Outstanding Seniors. She received a full scholarship to Texas Tech Medical School and completed her residency at Vanderbilt and a fellowship at Northwestern Medicine in Chicago. She is double board-certified in anesthesiology and pain medicine.
Dr. Murphy’s bicultural background enhances her adaptability and global perspective, contributing to her success. Among her many accolades, she has been named Chair of Innovation and Growth for the United Musculoskeletal Partners National Leadership Board, executive board member/Treasurer at the American Society of Pain and Neuroscience (ASPN), and Chair of the Women in Neuromodulation (WIN) committee at the North America Neuromodulation Society (NANS). In addition, she has delivered over 100 talks worldwide, advancing spinal cord stimulation and pain management. -
Dr. Scott G. Pritzlaff, MD, CIPS, FIPP, is a Professor of Anesthesiology and Program Director for the Pain Medicine Fellowship at UC Davis. An interventional pain physician, educator, and combat Navy veteran, Dr. Pritzlaff brings a well-rounded, mission-driven perspective to the field of Pain Medicine. His clinical and research work focuses on ultrasound-guided procedures and percutaneous nerve stimulation for the treatment of neuropathic pain, with an emphasis on peripheral nerve evaluation and innovation in pain and spine technologies.
Dr. Pritzlaff is a nationally recognized advocate for education reform in Pain Medicine. He has published on fellowship training standards and curriculum development. He is deeply committed to advancing the education, mentorship, and long-term success of pain fellows through structured, outcomes-based learning.